Table 4 Comorbidities and clinical outcomes of patient with high S/Co ratio for IgG against N protein.

Asthma

1 (8.3)

23 (28.8)

0.165

Pulmonary embolism

1 (25.0)

24 (26.7)

0.941

COPD

3 (30.0)

22 (25.9)

0.780

Emphysema

1 (50.0)

24 (26.1)

0.468

Chronic heart failure

1 (20.0)

24 (27.0)

0.733

Coronary artery disease

1 (12.5)

24 (27.9)

0.363

Atrial fibrillation

3 (33.3)

22 (25.6)

0.617

Hypertension

14 (24.6)

11 (28.2)

0.690

Stroke

1 (20.0)

23 (25.8)

0.772

Dementia

3 (30.0)

22 (25.6)

0.764

Chronic renal failure

1 (10.0)

23 (27.4)

0.259

Liver disease

1 (33.3)

24 (26.4)

0.789

Diabetes mellitus

7 (22.6)

18 (28.1)

0.74

Clinical symptoms

Cough

20 (33.3)

5 (13.9)

0.041, 3.10 (1.04–9.18)

Sputum

4 (57.1)

21 (24.4)

0.078, 4.12 (0.85–19.95)

Chest pain

4 (40.0)

21 (25.3)

0.329

Dyspnea

21 (35.0)

4 (10.5)

0.010, 4.57 (1.42–14.65)

Hemoptysis

2 (66.7)

23 (24.7)

0.148

Fever

19 (29.7)

6 (18.2)

0.224

Chills

9 (31.0)

16 (24.6)

0.516

Headache

4 (36.4)

21 (25.3)

0.439

Myalgia

3 (15.8)

22 (29.7)

0.230

Abdominal pain

2 (15.4)

23 (28.8)

0.323

Diarrhea

6 (30.0)

19 (25.7)

0.698

Nausea or vomiting

6 (40.0)

19 (24.4)

0.217

Altered mental status

3 (21.4)

22 (26.5)

0.689

Outcomes

Hospital LOS > 16 days

11 (47.8)

14 (18.4)

0.006, 4.060 (1.48–11.06)

MICU stay > 8 days

10 (71.4)

1 (7.1)

0.004, 32.50 (3.12–337.81)

MICU admission

11 (39.3)

14 (19.7)

0.047, 2.63 (1.01–6.86)

MICU death

3 (60.0)

22 (23.4)

0.092, 4.90 (0.77–31.27)

Hospital death

3 (30.0)

22 (24.7)

0.716

MICU stay (days)

17 (9.18 ± 10.35)

11 (16.82 ± 10.12)

0.065

Hospital stay (days)

74 (11.39 ± 10.33)

25 (17.68 ± 13.53)

0.041